Management Team
Cristina Glad, acting CEO
Doctor of Science, Biochemistry, MBA. Born 1952. Lives in Malmö, Sweden. CEO since 2013. Employed in 1987 by the former subsidiary Bioinvent Production AB. Member of the Royal Swedish Academy of Engineering Sciences. Member of the Boards of Ideonfonden AB, A1M Pharma AB and Lund University, Faculty of Medicine.
Shareholding: 1,044,221
Employee options: -
Björn Frendéus, Vice President, Preclinical Research
Doctor of Immunology. Born 1973. Lives in Landskrona, Sweden.
Employed since 2001. Graduated as the nation's
first student from the Swedish Foundation for Strategic
Research funded Biomedicine programmes within the
Infection & Vaccinology programme in 2001.
Shareholding: 804 (own and affiliated holdings)
Employee options: -
Per-Anders Johansson, Vice President, Quality Assurance and
Regulatory Affairs
Master of Science, Chemistry. Born 1955. Lives in Lund, Sweden.
Employed in 1984 by the former subsidiary Bioinvent Production AB.
Shareholding: 250,300
Employee options: -
Magnus Korsgren, Medical Director 
MD, Ph.D., associate professor at Lund University. Born 1969.
Lives in Södra Sandby, Sweden. Employed since 2010. During
2006-2010 he held various positions at AstraZeneca including
Clinical Pharmacology Physician and Disease Area Medical
Leader.
Shareholding: -
Employee options: 15,188
Fredrik Nilsson, Director Biopharmacy 
Ph.D. Biochemistry. Born 1960. Lives in Malmö, Sweden. Employed since
2002. 1999-2002 Associated Director and Head of Protein and
Peptide Analysis Group at AstraZeneca.
Shareholding: -
Employee options: -
Martin Wiles, Senior Vice President, Business Development
Ph.D. Chemistry, MBA. Born 1963. Lives in London, Great Britain.
Employed since 2003. Previously employed as Head of Business Development at KS Biomedix Holdings Plc, listed on the
London Stock Exchange.
Shareholding: -
Employee options: -